Ontology highlight
ABSTRACT:
SUBMITTER: Alimohammadi R
PROVIDER: S-EPMC9438359 | biostudies-literature | 2022 Sep
REPOSITORIES: biostudies-literature
Alimohammadi Reza R Porgoo Meysam M Eftekhary Mohamad M Kiaie Seyed Hossein SH Ansari Dezfouli Ehsan E Dehghani Maryam M Nasrollahi Kaveh K Malekshahabi Talieh T Heidari Maryam M Pouya Sedigheh S Alimohammadi Masoumeh M Sattari Khavas Dorsa D Modaresi Mohammad Sadra MS Ghasemi Mohammad Hossein MH Ramyar Hamed H Mohammadipour Fatemeh F Hamzelouei Fateme F Mofayezi Ahmadreza A Mottaghi Seyed Saeed SS Rahmati Amirhosein A Razzaznian Mohsen M Tirandazi Vista V Tat Mahdi M Borzouee Fatemeh F Sadeghi Hossein H Haji Mohammadi Melika M Rastegar Leila L Safar Sajadi Seyed Milad SM Ehsanbakhsh Hossein H Bazmbar Hamed H Baghernejadan Zeinab Z Shams Nouraei Maedeh M Pazooki Pouya P Pahlavanneshan Mina M Alishah Khadijeh K Nasiri Fateme F Mokhberian Neda N Mohammadi Seyedeh Shima SS Akar Shima S Niknam Hamidreza H Azizi Marzieh M Ajoudanian Mohammad M Moteallehi-Ardakani Mohammad Hossein MH Mousavi Shaegh Seyed Ali SA Ramezani Reihaneh R Salimi Vahid V Moazzami Reza R Hashemi Seyed Mahmoud SM Dehghanizadeh Somaye S Khoddami Vahid V
NPJ vaccines 20220902 1
At the forefront of biopharmaceutical industry, the messenger RNA (mRNA) technology offers a flexible and scalable platform to address the urgent need for world-wide immunization in pandemic situations. This strategic powerful platform has recently been used to immunize millions of people proving both of safety and highest level of clinical efficacy against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here we provide preclinical report of COReNAPCIN<sup>®</sup>; a ...[more]